Direct-Acting Antiviral Therapy in UK-based African Patients With HCV
Investigators analyzed UK residents with HCV born in Africa to examine the effectiveness of direct-acting antivirals in individuals from lower- or middle-income countries.
Hepatitis C
SOF/VEL Safe and Effective for HCV Patients With Severe Renal Disease
The researchers wanted to collect data about the real-world effectiveness and safety of SOF/VEL in patients with chronic HCV infection and severe renal impairment.
Liver Cancer Profile Differs in Black Patients With Hep C
Black patients have better liver function at the time of hepatocellular carcinoma diagnosis along with less early-stage HCC and larger tumors.
High Prevalence of HCV Infection in MSM Regardless of HIV Status
The researchers’ objective was to determine the prevalence of HCV antibodies among MSM with and without HIV, as well as factors associated with HCV infection among MSM.
Kidney Transplant Outcomes Similar With Hep C+ Donors
At 1 year after transplant, kidney allograft function, rejection rates similar regardless of donor hepatitis C status.
Controversy: Protecting People Who Use Drugs During COVID-19
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
Despite Hepatitis C Virus Status, Many Positive Liver Allograft Donors Were Healthier and Younger
Increased utilization of HCV-positive liver allografts for LT is seen as one of the ways to counter national organ shortages, so researchers set out to better characterize the allografts that come from HCV-positive donors from specific regions.
Hepatocellular Carcinoma May Present at Earlier Stage of Liver Disease in Black Patients With HCV
Investigators evaluated the incidence of HCC in the absence of cirrhosis in Black patients with HCV.
American College of Physicians Updates Best Practice Advice for Chronic HCV
Based on guidelines issued by the World Health Organizations in 2018, the American College of Physicians has issued best practice advice that simplifies and improves treatment of chronic hepatitis C virus.
Liver Stiffness Post HCV Anti-Viral Therapy Associated With Several Adverse Outcomes
Measuring liver stiffness should be considered after anti-viral treatment because it predicts adverse outcomes even beyond routinely available clinical predictors.
-
Loading...
-
Loading...
Next post in Hepatitis
